{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:11:25Z","timestamp":1776283885681,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T00:00:00Z","timestamp":1173139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T00:00:00Z","timestamp":1173139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.mp.4001967","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T06:23:40Z","timestamp":1173162220000},"page":"671-680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Validation of amyloid-\u03b2 peptides in CSF diagnosis of neurodegenerative dementias"],"prefix":"10.1038","volume":"12","author":[{"given":"M","family":"Bibl","sequence":"first","affiliation":[]},{"given":"B","family":"Mollenhauer","sequence":"additional","affiliation":[]},{"given":"P","family":"Lewczuk","sequence":"additional","affiliation":[]},{"given":"H","family":"Esselmann","sequence":"additional","affiliation":[]},{"given":"S","family":"Wolf","sequence":"additional","affiliation":[]},{"given":"C","family":"Trenkwalder","sequence":"additional","affiliation":[]},{"given":"M","family":"Otto","sequence":"additional","affiliation":[]},{"given":"G","family":"Stiens","sequence":"additional","affiliation":[]},{"given":"E","family":"R\u00fcther","sequence":"additional","affiliation":[]},{"given":"J","family":"Kornhuber","sequence":"additional","affiliation":[]},{"given":"J","family":"Wiltfang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,3,6]]},"reference":[{"key":"BF4001967_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW . Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885\u2013890.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF4001967_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-7091-6846-2_11","volume":"51","author":"K Jendroska","year":"1997","unstructured":"Jendroska K, Kashiwagi M, Sassoon J, Daniel SE . Amyloid beta-peptide and its relationship with dementia in Lewy body disease. J Neural Transm Suppl 1997; 51: 137\u2013144.","journal-title":"J Neural Transm Suppl"},{"key":"BF4001967_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/jsbi.2000.4270","volume":"130","author":"SE Arnold","year":"2000","unstructured":"Arnold SE, Han LY, Clark CM, Grossman M, Trojanowski JQ . Quantitative neurohistological features of frontotemporal degeneration. J Struct Biol 2000; 130: 271\u2013279.","journal-title":"J Struct Biol"},{"key":"BF4001967_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S et al. Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37\/38\/39 in addition to 1-40\/42 in Alzheimer's disease and patients with chronic neuroinflammation. J Neurochem 2002; 81: 481\u2013496.","journal-title":"J Neurochem"},{"key":"BF4001967_CR5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/brain\/awl063","volume":"129","author":"M Bibl","year":"2006","unstructured":"Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki HW, Sparbier K et al. CSF amyloid-\u03b2-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain 2006a; 129: 1177\u20131187.","journal-title":"Brain"},{"key":"BF4001967_CR6","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/jnnp.2005.084673","volume":"77","author":"B Mollenhauer","year":"2006","unstructured":"Mollenhauer B, Bibl M, Esselmann H, Steinacker P, Ciesielcyk B, Neubert K et al. Slective reduction of amyloid beta42 discriminates Alzheimer's from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation. J Neurol Neurosurg Psychiatry 2006; 77: 1201\u20131203.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF4001967_CR7","first-page":"1448","volume":"313","author":"World Medical Organisation","year":"1996","unstructured":"World Medical Organisation. Declaration of Helsinki. Br Med J 1996; 313: 1448\u20131449.","journal-title":"Br Med J"},{"key":"BF4001967_CR8","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1002\/elps.200305992","volume":"25","author":"M Bibl","year":"2004","unstructured":"Bibl M, Esselmann H, Otto M, Lewczuk P, Cepek L, R\u00fcther E et al. Cerebrospinal fluid (CSF) amyloid beta (A\u03b2) peptide patterns in Alzheimer's disease (AD) patients and non-demented controls depend on sample pre-treatment: indication of carrier-mediated epitope masking of A\u03b2 peptides. Electrophoresis 2004; 25: 2912\u20132918.","journal-title":"Electrophoresis"},{"key":"BF4001967_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939\u2013944.","journal-title":"Neurology"},{"key":"BF4001967_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113\u20131124.","journal-title":"Neurology"},{"key":"BF4001967_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546\u20131554.","journal-title":"Neurology"},{"key":"BF4001967_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1212\/WNL.43.2.243","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjutti T, Cummings JL, Masdeu JC, Garcia JH et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 243\u2013245.","journal-title":"Neurology"},{"key":"BF4001967_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ . The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745\u2013752.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF4001967_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2176\/nmc.44.222","volume":"44","author":"M Ishikawa","year":"2004","unstructured":"Ishikawa M . Clinical guidelines for idiopathic normal pressure hydrocephalus. Neurol Med Chir 2004; 44: 222\u2013223.","journal-title":"Neurol Med Chir"},{"key":"BF4001967_CR15","first-page":"167","volume":"6","author":"I Litvan","year":"1997","unstructured":"Litvan I . Progressive supranuclear palsy and corticobasal degeneration. Bailliere's Clin Neurol 1997; 6: 167\u2013185.","journal-title":"Bailliere's Clin Neurol"},{"key":"BF4001967_CR16","first-page":"361","volume":"73","author":"World Health Organization","year":"1998","unstructured":"World Health Organization. Human Transmissible Spongiform Encephalopathy. Weekly Epidemiological Record 1998; 73: 361\u2013365.","journal-title":"Weekly Epidemiological Record"},{"key":"BF4001967_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/(SICI)1099-1166(199804)13:4<203::AID-GPS734>3.0.CO;2-B","volume":"13","author":"D Oslin","year":"1998","unstructured":"Oslin D, Aktinsson RM, Smith DM, Hendrie H . Alcohol related dementia: proposed clinical criteria. Int J Geriatr Psychiatry 1998; 13: 203\u2013212.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BF4001967_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000090363","volume":"2","author":"PD Mehta","year":"2005","unstructured":"Mehta PD, Pirttila T . Increased cerebrospinal fluid A beta38\/A beta42 ratio in Alzheimer's disease. Neurodegener Dis 2005; 2: 242\u2013245.","journal-title":"Neurodegener Dis"},{"key":"BF4001967_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","volume":"1","author":"K Blennow","year":"2004","unstructured":"Blennow K . Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 2004; 1: 213\u2013225.","journal-title":"NeuroRx"},{"key":"BF4001967_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/15622970510029786","volume":"6","author":"J Wiltfang","year":"2005","unstructured":"Wiltfang J, Lewczuk P, Riederer P, Grunblatt E, Hock C, Scheltens P et al. Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry 2005; 6: 69\u201384.","journal-title":"World J Biol Psychiatry"},{"key":"BF4001967_CR21","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A, Schoonderwald HC, Riemenschneider M, De Deyn PP et al. Improved discrimination of AD-patients using \u03b2-amyloid (1-42) and tau levels in CSF. Neurology 1999; 52: 1555\u20131562.","journal-title":"Neurology"},{"key":"BF4001967_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000083178","volume":"19","author":"B Mollenhauer","year":"2005","unstructured":"Mollenhauer B, Cepek L, Bibl M, Wiltfang J, Schulz-Schaeffer WJ, Ciesielczyk B et al. Tau protein, beta-amyloid (1-42) and S100B protein in cerebrospinal fluid of patients with Dementia with Lewy Bodies. Dement Geriatr Cogn Disord 2005; 19: 164\u2013170.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BF4001967_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ana.20477","volume":"57","author":"M Grossman","year":"2005","unstructured":"Grossman M, Farmer J, Light S, Work M, Moore P, Van Deerlin V et al. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol 2005; 57: 721\u2013729.","journal-title":"Ann Neurol"},{"key":"BF4001967_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ana.10661","volume":"54","author":"J Wiltfang","year":"2003","unstructured":"Wiltfang J, Esselmann H, Smirnov A, Bibl M, Cepek L, Steinacker P et al. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Ann Neurol 2003; 54: 263\u2013267.","journal-title":"Ann Neurol"},{"key":"BF4001967_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","volume":"61","author":"H Hampel","year":"2004","unstructured":"Hampel H, Buerger K, Zinkowski R, Teipel SJ, Andreasen N, Sj\u00f6gren M et al. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer's disease \u2013 a comparative study. Arch Gen Psychiatry 2004; 61: 95\u2013102.","journal-title":"Arch Gen Psychiatry"},{"key":"BF4001967_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.410380413","volume":"38","author":"R Motter","year":"1995","unstructured":"Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D et al. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995; 38: 643\u2013648.","journal-title":"Ann Neurol"},{"key":"BF4001967_CR27","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1006\/bbrc.1996.0940","volume":"223","author":"AR Koudinov","year":"1996","unstructured":"Koudinov AR, Koudinova NV, Kumar A, Beavis RC, Ghiso J . Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with density lipoproteins. Biochem Biophys Res Commun 1996; 223: 592\u2013597.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF4001967_CR28","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1074\/jbc.270.16.9564","volume":"270","author":"MB Podlisny","year":"1995","unstructured":"Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB et al. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 1995; 270: 9564\u20139570.","journal-title":"J Biol Chem"},{"key":"BF4001967_CR29","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/nm0798-832","volume":"4","author":"M Pitschke","year":"1998","unstructured":"Pitschke M, Prior R, Haupt M, Riesner D . Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy. Nat Med 1998; 4: 832\u2013834.","journal-title":"Nat Med"},{"key":"BF4001967_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","volume":"70","author":"M Sj\u00f6gren","year":"2001","unstructured":"Sj\u00f6gren M, Davidsson P, Tullberg M, Minthon L, Wallin A, Wikkelso C et al. Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 70: 624\u2013630.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF4001967_CR31","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/WNL.54.10.1960","volume":"54","author":"M Sj\u00f6gren","year":"2000","unstructured":"Sj\u00f6gren M, Rosgren L, Minthon L, Davidson P, Blennow K, Wallin A . Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD. Neurology 2000; 54: 1960\u20131964.","journal-title":"Neurology"},{"key":"BF4001967_CR32","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/WNL.58.11.1622","volume":"58","author":"M Riemenschneider","year":"2002","unstructured":"Riemenschneider M, Wagenpfeil S, Diehl J, Lautenschlager N, Theml T, Heldmann B et al. Tau and A\u03b242 protein in CSF of patients with frontotemporal degeneration. Neurology 2002; 58: 1622\u20131628.","journal-title":"Neurology"},{"key":"BF4001967_CR33","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1212\/WNL.58.11.1585","volume":"58","author":"D Galasko","year":"2002","unstructured":"Galasko D, Marder K . Picking away at frontotemporal dementia. Neurology 2002; 58: 1585\u20131586.","journal-title":"Neurology"},{"key":"BF4001967_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00001756-200002070-00013","volume":"11","author":"C Andersen","year":"2000","unstructured":"Andersen C, Jensen M, Lannfelt L, Lindau M, Wahlund LO . Amyloid A\u03b240 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia. Neuroreport 2000; 11: 287\u2013290.","journal-title":"Neuroreport"},{"key":"BF4001967_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.20083","volume":"55","author":"B Dermaut","year":"2004","unstructured":"Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rademakers R, Saerens J et al. A novel presenilin 1 mutation associated with Pick's disease but not \u03b2-amyloid plaques. Ann Neurol 2004; 55: 617\u2013626.","journal-title":"Ann Neurol"},{"key":"BF4001967_CR36","doi-asserted-by":"crossref","unstructured":"Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B et al. Evaluation of CSF-tau and CSF-A\u03b242 as diagnostic markers for Alzheimer disease in clinical practice. 2001; 58: 373\u2013379.","DOI":"10.1001\/archneur.58.3.373"},{"key":"BF4001967_CR37","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00702-006-0537-z","volume":"113","author":"M Bibl","year":"2006","unstructured":"Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Trenkwalder C, Brechlin P et al. CSF diagnosis of Alzheimer's disease and dementias with Lewy bodies. J Neural Transm 2006b; 113: 1771\u20131778.","journal-title":"J Neural Transm"},{"key":"BF4001967_CR38","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1021\/bi0272151","volume":"42","author":"J Dong","year":"2003","unstructured":"Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G et al. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 2003; 42: 2768\u20132773.","journal-title":"Biochemistry"},{"key":"BF4001967_CR39","doi-asserted-by":"publisher","first-page":"9141","DOI":"10.1073\/pnas.92.20.9141","volume":"92","author":"M Yoshimoto","year":"1995","unstructured":"Yoshimoto M, Iwai A, Kang D, Otero DA, Xia Y, Saitoh T . NACP, the precursor of the non-amyloid beta\/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. Proc Natl Acad Sci USA 1995; 92: 9141\u20139145.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001967_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/mabi.200400189","volume":"5","author":"CE Giacomelli","year":"2005","unstructured":"Giacomelli CE, Norde W . Conformational changes in the amyloid \u03b2 peptide (1-40) adsorbed on solid surfaces. Macromol Biosci 2005; 5: 401\u2013407.","journal-title":"Macromol Biosci"},{"key":"BF4001967_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0969-2126(03)00031-5","volume":"11","author":"DK Klimov","year":"2003","unstructured":"Klimov DK, Thirumalai D . Dissecting the assembly of A\u03b216-22 amyloid peptides into antiparallel \u03b2 sheets. Structure 2003; 11: 295\u2013307.","journal-title":"Structure"},{"key":"BF4001967_CR42","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1006\/jmbi.2001.4970","volume":"312","author":"MD Kirkitadze","year":"2001","unstructured":"Kirkitadze MD, Condron MM, Teplow DB . Identification and characterization of key kinetic intermediates in amyloid \u03b2-protein fibrillogenesis. J Mol Biol 2001; 312: 1103\u20131119.","journal-title":"J Mol Biol"},{"key":"BF4001967_CR43","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.2174\/0929867033456422","volume":"10","author":"DA Butterfield","year":"2003","unstructured":"Butterfield DA . Amyloid \u03b2-peptide (1-42)-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences. Curr Med Chem 2003; 10: 2651\u20132659.","journal-title":"Curr Med Chem"},{"key":"BF4001967_CR44","doi-asserted-by":"publisher","first-page":"42959","DOI":"10.1074\/jbc.M305494200","volume":"278","author":"KJ Barnham","year":"2003","unstructured":"Barnham KJ, Ciccotosto GD, Tickler AK, Ali FE, Smith DG, Williamson MA et al. Neurotoxic, redox-competent Alzheimer's \u03b2-Amyloid is released from lipid membrane by methionine oxidation. J Biol Chem 2003; 278: 42959\u201342965.","journal-title":"J Biol Chem"},{"key":"BF4001967_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","volume":"25","author":"P Lewczuk","year":"2004","unstructured":"Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK et al. Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta 42, Abeta42\/ Abeta40 ratio and total tau. Neurobiol Aging 2004; 25: 273\u2013281.","journal-title":"Neurobiol Aging"},{"key":"BF4001967_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.20508","volume":"58","author":"NS Schoonenboom","year":"2005","unstructured":"Schoonenboom NS, Mulder C, Van Kamp GJ, Mehta SP, Scheltens P, Blankenstein MA et al. Amyloid \u03b2 38, 40 and 42 species in cerebrospinal fluid: more of the same? Ann Neurol 2005; 58: 139\u2013142.","journal-title":"Ann Neurol"},{"key":"BF4001967_CR47","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU et al. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 2001; 414: 212\u2013216.","journal-title":"Nature"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4001967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001967","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T12:22:22Z","timestamp":1648815742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4001967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,6]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BF4001967"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4001967","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,6]]},"assertion":[{"value":"24 October 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}